ArticlemAbs2017

Demonstration of physicochemical and functional similarity between the proposed biosimilar adalimumab MSB11022 and Humira®.

Laurent Magnenat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.